Niagen Bioscience Statistics
Total Valuation
NAGE has a market cap or net worth of $336.34 million. The enterprise value is $274.52 million.
| Market Cap | 336.34M |
| Enterprise Value | 274.52M |
Important Dates
The last earnings date was Wednesday, March 4, 2026, after market close.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NAGE has 80.08 million shares outstanding. The number of shares has increased by 9.36% in one year.
| Current Share Class | 80.25M |
| Shares Outstanding | 80.08M |
| Shares Change (YoY) | +9.36% |
| Shares Change (QoQ) | -2.51% |
| Owned by Insiders (%) | 29.34% |
| Owned by Institutions (%) | 40.35% |
| Float | 52.89M |
Valuation Ratios
The trailing PE ratio is 21.00 and the forward PE ratio is 15.56.
| PE Ratio | 21.00 |
| Forward PE | 15.56 |
| PS Ratio | 2.60 |
| Forward PS | 2.27 |
| PB Ratio | 4.38 |
| P/TBV Ratio | 4.75 |
| P/FCF Ratio | 25.46 |
| P/OCF Ratio | 24.91 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.20, with an EV/FCF ratio of 20.78.
| EV / Earnings | 15.79 |
| EV / Sales | 2.12 |
| EV / EBITDA | 18.20 |
| EV / EBIT | 19.20 |
| EV / FCF | 20.78 |
Financial Position
The company has a current ratio of 4.86, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.86 |
| Quick Ratio | 3.73 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.17 |
| Debt / FCF | 0.21 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 28.35% and return on invested capital (ROIC) is 112.39%.
| Return on Equity (ROE) | 28.35% |
| Return on Assets (ROA) | 10.23% |
| Return on Invested Capital (ROIC) | 112.39% |
| Return on Capital Employed (ROCE) | 16.53% |
| Weighted Average Cost of Capital (WACC) | 16.39% |
| Revenue Per Employee | $1.11M |
| Profits Per Employee | $148,564 |
| Employee Count | 117 |
| Asset Turnover | 1.48 |
| Inventory Turnover | 3.12 |
Taxes
In the past 12 months, NAGE has paid $810,000 in taxes.
| Income Tax | 810,000 |
| Effective Tax Rate | 4.45% |
Stock Price Statistics
The stock price has decreased by -45.10% in the last 52 weeks. The beta is 2.23, so NAGE's price volatility has been higher than the market average.
| Beta (5Y) | 2.23 |
| 52-Week Price Change | -45.10% |
| 50-Day Moving Average | 5.25 |
| 200-Day Moving Average | 7.96 |
| Relative Strength Index (RSI) | 27.87 |
| Average Volume (20 Days) | 1,938,307 |
Short Selling Information
The latest short interest is 5.58 million, so 6.97% of the outstanding shares have been sold short.
| Short Interest | 5.58M |
| Short Previous Month | 6.46M |
| Short % of Shares Out | 6.97% |
| Short % of Float | 10.55% |
| Short Ratio (days to cover) | 3.59 |
Income Statement
In the last 12 months, NAGE had revenue of $129.42 million and earned $17.38 million in profits. Earnings per share was $0.20.
| Revenue | 129.42M |
| Gross Profit | 83.19M |
| Operating Income | 14.30M |
| Pretax Income | 18.19M |
| Net Income | 17.38M |
| EBITDA | 15.08M |
| EBIT | 14.30M |
| Earnings Per Share (EPS) | $0.20 |
Balance Sheet
The company has $64.64 million in cash and $2.82 million in debt, with a net cash position of $61.82 million or $0.77 per share.
| Cash & Cash Equivalents | 64.64M |
| Total Debt | 2.82M |
| Net Cash | 61.82M |
| Net Cash Per Share | $0.77 |
| Equity (Book Value) | 76.53M |
| Book Value Per Share | 0.96 |
| Working Capital | 76.89M |
Cash Flow
In the last 12 months, operating cash flow was $13.50 million and capital expenditures -$292,000, giving a free cash flow of $13.21 million.
| Operating Cash Flow | 13.50M |
| Capital Expenditures | -292,000 |
| Depreciation & Amortization | 785,000 |
| Net Borrowing | -12,000 |
| Free Cash Flow | 13.21M |
| FCF Per Share | $0.16 |
Margins
Gross margin is 64.28%, with operating and profit margins of 11.05% and 13.43%.
| Gross Margin | 64.28% |
| Operating Margin | 11.05% |
| Pretax Margin | 14.06% |
| Profit Margin | 13.43% |
| EBITDA Margin | 11.65% |
| EBIT Margin | 11.05% |
| FCF Margin | 10.21% |
Dividends & Yields
NAGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.36% |
| Shareholder Yield | -9.36% |
| Earnings Yield | 5.17% |
| FCF Yield | 3.93% |
Analyst Forecast
The average price target for NAGE is $16.00, which is 280.95% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.00 |
| Price Target Difference | 280.95% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 13, 2016. It was a reverse split with a ratio of 1:3.
| Last Split Date | Apr 13, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
NAGE has an Altman Z-Score of 13.56 and a Piotroski F-Score of 5.
| Altman Z-Score | 13.56 |
| Piotroski F-Score | 5 |